What Researchers Did
Researchers reported on two patients who developed delayed brain problems after carbon monoxide poisoning and were treated with hyperbaric oxygen therapy.
What They Found
The two patients with carbon monoxide-induced delayed neuropsychiatric sequelae were successfully treated with hyperbaric oxygen therapy. Each patient received more than 100 sessions of HBOT. The Frontal Assessment Battery (FAB) was used to objectively measure their improvement.
What This Means for Canadian Patients
For Canadian patients experiencing delayed brain issues after carbon monoxide poisoning, this case report suggests HBOT could be a potential treatment option. While not a large study, it offers an example of how HBOT might help improve cognitive function in such cases.
Canadian Relevance
This study was not conducted by Canadian authors or in Canada. However, it covers carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
As a case report involving only two patients, this study cannot definitively prove the effectiveness of HBOT for carbon monoxide-induced delayed neuropsychiatric sequelae.